Use of preferentially replicating bacteria for the treatment of cancer.
Sznol
M
M
Vion Pharmaceuticals Inc., New Haven, Connecticut 06511, USA. msznol@vionpharm.com
Lin
S L
SL
Bermudes
D
D
Zheng
L M
LM
King
I
I
D000818:Animals; D001691:Biological Therapy; D002455:Cell Division; D005818:Genetic Engineering; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D012475:Salmonella / Q000235:genetics / Q000502:physiology*